Right now, the care management program services are only available to individuals through participating health plans, health systems and employers.
Unplanned health events tend to be the costliest. That’s why we inform and engage people early on and use data and advanced analytics to identify those who:
• Have the disease already
• Are at risk of progressing to end-stage renal disease
This proactive approach can lower costs while resulting in fewer
health-related events, fewer hospital days and less unplanned dialysis.
The HemoCare Hemodialysis System* is the subject of a clinical trial. The trial is designed to evaluate the safety and efficacy of the device for administration of home hemodialysis. The device includes safety features and is designed to make home hemodialysis simple for patients. Home hemodialysis helps facilitate longer, more frequent dialysis treatments as compared to in-center treatments, and published clinical research has found that longer, more frequent hemodialysis treatments result in better health outcomes in appropriate patient populations.1,2,3 The clinical trial of up to 70 patients will be conducted at up to 10 sites in the United States.
Whether you’re already using a home treatment or going to a clinic, it’s always helpful to explore your options. The best place to start is by talking to your doctor and letting them know you’re interested. They may already know how to refer you to the program. But if not, just ask them to check our website for information.
*CAUTION--Investigational device. Limited by Federal (or United States) law to investigational use.
1Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007; 298(11): 1291–1299. Accessed
January 8, 2020.
2Kotanko P, Garg AX, Depner T, et al. National Center for Biotechnology Information, U.S. National Library of Medicine. Effects of frequent hemodialysis on blood pressure: results from the randomized frequent hemodialysis network trials. Hemodialysis International. 2015; 19(3): 386–401. Accessed January 8, 2020.
3Nesrallah GE, Lindsay RM. Cuerden MS, et al. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. JASN. April 2012; 23(4): 696–705. Accessed January 8, 2020.
Links to various non-CVS Kidney Care sites are provided for your convenience only. CVS Kidney Care and its subsidiary companies are not responsible or liable for the content, accuracy, or privacy practices of linked sites, or for products or services described on these sites.
The information you will be accessing is provided by another organization or vendor. If you do not intend to leave our site, close this message.